Cargando…

FRI077 Efficacy Of Anti-obesity Medications Among Breast Cancer Survivors Taking Aromatase Inhibitors

Disclosure: S. Fansa: None. W. Ghusn: None. E. Tama: None. B. Nicolalde: None. D. Anazco: None. S. D'Andre: None. S. Faubion: None. C. Shufelt: None. A. Acosta: None. M.D. Hurtado: None. Background: Aromatase inhibitors (AIs) block estrogen synthesis and are used as adjuvant treatment for breas...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fansa, Sima, Ghusn, Wissam, Tama, Elif, Nicolalde, Bryan, Anazco, Diego, D'Andre, Stacy, Faubion, Stephanie, Shufelt, Chrisandra, Acosta, Andres, Hurtado, Maria D
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2023
Materias:	Adipose Tissue, Appetite, & Obesity
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10555325/ http://dx.doi.org/10.1210/jendso/bvad114.087

Ejemplares similares

FRI078 Real-World Weight Loss Outcomes And Safety Of Tirzepatide, A Novel Dual GIP And GLP-1 Receptor Agonist
por: Fansa, Sima, et al.
Publicado: (2023)

FRI026 PPARγ Antagonists Induce Aromatase Transcription In Human Adipose Tissue Cells
por: Ardenkjær-Skinnerup, Jacob, et al.
Publicado: (2023)

FRI028 Multiple Symmetric Lipomatosis As A Model For Understanding The Importance Of Mitochondria Function On Adipose Tissue Biology
por: Foss de Freitas, Maria Cristina, et al.
Publicado: (2023)

FRI069 Treatment With Mibavademab, A Novel Leptin Receptor Agonist, Is Associated With Improvement In Weight And Associated Comorbidities In Congenital Leptin Deficiency
por: Ozsu, Elif, et al.
Publicado: (2023)

FRI057 Drug Concentrations And Dosing Considerations For Mibavademab, A Novel Leptin Receptor Agonist, In Individuals With Generalized Lipodystrophy
por: Mendell, Jeanne, et al.
Publicado: (2023)

FRI014 Exploring The Epigenetic Fingerprint Of Sedentary Behavior
por: Brener, Avivit, et al.
Publicado: (2023)

FRI046 Clinical Phenotyping Of Adults With Genetic Obesity
por: Welling, Mila Sofie, et al.
Publicado: (2023)

FRI059 Long-term Follow-up On Partial Lipodystrophy Treated With Leptin Receptor Agonist Mibavademab(REGN4461)
por: Foss de Freitas, Maria Cristina, et al.
Publicado: (2023)

FRI032 Cellular Insights Into Metabolically Healthy And Unhealthy Obesity
por: Petersen, Max C, et al.
Publicado: (2023)

FRI006 Appetite And Food Intake-regulating Hormones In Patients With Craniopharyngioma
por: Martins, Clarissa S, et al.
Publicado: (2023)

FRI039 Endothelial Dysfunction Is Associated With Adiponectin And Leptin In Adolescents With PCOS
por: Gavryutina, Irina, et al.
Publicado: (2023)

FRI063 Effectiveness Of Liraglutide In Treating Obesity And Improving Hepatic Steatosis
por: Alfadda, Assim Abdulaziz, et al.
Publicado: (2023)

FRI019 Mono(ADP-Ribosyl)ation Of Ribosomal Proteins During Adipogenesis
por: Tan, Xinrui, et al.
Publicado: (2023)

FRI045 Impact Of Morbid Obesity On Lupus Hospitalizations: A Nationwide Analysis
por: Sami, Faria, et al.
Publicado: (2023)

FRI007 Kisspeptin Does Not Affect Food Intake In Women With Overweight Or Obesity
por: Izzi-Engbeaya, Chioma, et al.
Publicado: (2023)

FRI054 Partial Lipodystrophy As A Manifestation Of Autoimmune Polyglandular Syndrome 1
por: Agarwal, Shubham, et al.
Publicado: (2023)

FRI055 LYNC-LD: Prospective Multicenter Natural History Study Of Lipodystrophy Syndromes To Determine Prevalence, Incidence And Predictors Of Diabetes And Severe Hypertriglyceridemia, And Their Complications
por: Foss de Freitas, Maria Cristina, et al.
Publicado: (2023)

FRI058 Treatment With Mibavademab, A Novel Leptin Receptor Agonist, Is Associated With Improvement In Metabolic Parameters In Individuals With Generalized Lipodystrophy
por: Olenchock, Ben, et al.
Publicado: (2023)

FRI041 Obesity-associated Diaphragm Weakness Is Not Explained By Defects At The Level Of The Contractile Apparatus
por: Verma, Romil Kaul, et al.
Publicado: (2023)

FRI056 Effect Of 48 Hour Of Metreleptin In Humans With Lipodystrophy During Controlled Feeding
por: Bukhari, Khulood M, et al.
Publicado: (2023)

FRI021 Adipocyte Subpopulations Regulate The Lipolytic Response And Inflammatory Cytokine Action In Obesity
por: Huang, Jun, et al.
Publicado: (2023)

FRI005 Appetite Response To Short-term Energy Restriction In Young Healthy Women
por: Choi, Gloria E, et al.
Publicado: (2023)

FRI020 Adipocyte Subpopulations Regulate Growth Hormone-induced Lipolysis And Insulin Resistance
por: Siyar, Sohana, et al.
Publicado: (2023)

FRI082 Impact Of Setmelanotide On Metabolic Parameters And Vital Signs In Patients With Hypothalamic Obesity
por: Jennifer Abuzzahab, M, et al.
Publicado: (2023)

FRI105 Getting Fam-iliar With Familial Chylomicronemia Syndrome: A Case Report
por: Jimenez, Aaron-Ross, et al.
Publicado: (2023)

FRI060 Real World Experience Of Weight Management In Low Socioeconomic Community Clinic
por: West, Brittany Ann, et al.
Publicado: (2023)

FRI042 Worsening Shortness Of Breath After A Mild Case Of Covid-19
por: Qureshi, Khurrum, et al.
Publicado: (2023)

FRI025 Succinate Receptor Activation Increases Respiration In Human But Not Murine Brown Adipocytes
por: McNeill, Ben T, et al.
Publicado: (2023)

FRI018 A Novel Truncating Variant Of EBF2 Disrupts Human Adipocyte Differentiation In Lipodystrophy Syndromes: An Example Of A Discovery From A Clinical Translational Pipeline
por: Foss de Freitas, Maria Cristina, et al.
Publicado: (2023)

FRI051 Lean Mass And Fat Mass Across Different Age Groups In The Thai Population
por: Charoenngam, Nipith, et al.
Publicado: (2023)

FRI003 Oxytocin Response To Feeding Predicts Reward-driven Calorie Consumption In Adults With Obesity
por: Boutin, Regine, et al.
Publicado: (2023)

FRI013 Free Fatty Acid Receptors 2 And 3 Mediate The Beneficial Effects Of Fiber
por: Pandya, Nupur S, et al.
Publicado: (2023)

FRI033 Metabolically Healthy Obesity In A Young Population Assisted By The Family Health Strategy
por: Boghossian, Rodney Barbera, et al.
Publicado: (2023)

FRI012 Exploring The Role Of FFA2 In Western Diet-induced Obesity And Metabolic Changes
por: Nnyamah, Christine, et al.
Publicado: (2023)

FRI073 Use Of Obesogenic Medications Among Patients With Type 2 Diabetes In The Dominican Republic
por: Agramonte Villar, Scarlet P, et al.
Publicado: (2023)

FRI002 IGF-1R Targeting As A Strategy For Reducing Obesity And Improving Metabolism
por: Al-Samerria, Sarmed, et al.
Publicado: (2023)

MON-094 Aromatase Inhibitors and Weight Loss in Severely Obese Male Veterans with Hypogonadism: A Randomized Clinical Trial
por: Colleluori, Georgia, et al.
Publicado: (2019)

FRI062 Efficacy And Durability Of A Very Low Calorie Ketogenic Diet Protocol On Cardiometabolic Parameters
por: Camajani, Elisabetta, et al.
Publicado: (2023)

FRI030 The Clinical Significance Of The Oxidative Status Evaluation Among Insulin Resistant Overweight And Obese Patients
por: Popławska-Kita, Anna, et al.
Publicado: (2023)

FRI010 Human Gut Microbiota And Metabolic Profiles Are Associated With Obesity In Five African-Origin Populations
por: Jorgensen, Julianne, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_g1acsf6ucjkgbb6id0147m9vdv